BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Allergy to pollen, Breast, Hematopoietic cell, Lipopolysaccharide, rs2300478, MYC)
Bookmark Forward

QuickView for Suv39h (gene)


Body Atlas

Most Correlated Tissues

  1. Dendritic (plasmacytoid) cell
  2. Skeletal muscle psoas
  3. T Lymphocyte (regulatory) of peripheral blood
  4. Hematopoietic stem cell of bone marrow
  5. Monocyte of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Pyloric ulcer
  2. Rhinitis
  3. Temperature-associated finding
  4. Hypertrophic cardiomyopathy
  5. Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 4-hydroxyestradiol-17 beta
  2. NVP-TAE684
  3. 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one
  4. KIN001-260
  5. 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. hsa-miR-34a-5p
  2. SMCHD1
  3. TLK2
  4. CHKA
  5. COL7A1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia-reperfusion injury.
  2. Histone H3 Methyltransferase Suv39h1 Prevents Myogenic Terminal Differentiation by Repressing MEF2 A…
  3. Pericentric H3K9me3 Formation by HP1 Interaction-defective Histone Methyltransferase Suv39h1.
  4. Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21(WAF1) in mesan…
  5. Regulation of the SUV39H Family Methyltransferases: Insights from Fission Yeast.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for Suv39h
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.